Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Diagnostic, Pathology Industry Seen Making Consolidation Moves

This article was originally published in PharmAsia News

Executive Summary

India's diagnostics and pathology industry is expected to begin a consolidation move as it continues growing at a rate of 10 percent to 12 percent a year. The head of an investment firm said several regional players are attempting to become the nation's first national player, but the route to get there is time-consuming and expensive. That, he said, leaves the firms with little choice but to merger with companies in similar situations. A consultant said diagnostics and pathology laboratories need to reduce their costs and could do that only by consolidating as they attempt to expand business. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts